Ziqi Lin

412 total citations
18 papers, 273 citations indexed

About

Ziqi Lin is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Ziqi Lin has authored 18 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Biomedical Engineering. Recurrent topics in Ziqi Lin's work include Nanoplatforms for cancer theranostics (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Parasitic Infections and Diagnostics (2 papers). Ziqi Lin is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Parasitic Infections and Diagnostics (2 papers). Ziqi Lin collaborates with scholars based in China, Macao and Taiwan. Ziqi Lin's co-authors include Xincheng Lu, Liting Lu, Juji Dai, Wanqin Liao, Li Zhang, Xiaowei Dai, Yalei Qi, Jin Hu, Zheng Zhang and Hang Fai Kwok and has published in prestigious journals such as PLoS ONE, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Ziqi Lin

17 papers receiving 264 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ziqi Lin 129 69 49 43 37 18 273
Qian‐Zhi Ni 91 0.7× 45 0.7× 37 0.8× 34 0.8× 26 0.7× 17 221
Fuqiang Huang 168 1.3× 65 0.9× 32 0.7× 16 0.4× 21 0.6× 21 279
Kerstin Rönsch 170 1.3× 101 1.5× 87 1.8× 29 0.7× 26 0.7× 8 325
Indi P. Joore 282 2.2× 27 0.4× 92 1.9× 42 1.0× 27 0.7× 5 416
Manning Qian 234 1.8× 34 0.5× 123 2.5× 11 0.3× 19 0.5× 11 387
H. Yue 269 2.1× 25 0.4× 30 0.6× 16 0.4× 20 0.5× 15 374
Bowen Liu 196 1.5× 82 1.2× 41 0.8× 34 0.8× 37 1.0× 27 329

Countries citing papers authored by Ziqi Lin

Since Specialization
Citations

This map shows the geographic impact of Ziqi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqi Lin more than expected).

Fields of papers citing papers by Ziqi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqi Lin. The network helps show where Ziqi Lin may publish in the future.

Co-authorship network of co-authors of Ziqi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqi Lin. A scholar is included among the top collaborators of Ziqi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqi Lin. Ziqi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liao, Rui, Yuequan Wang, Ziqi Lin, et al.. (2025). A chemotherapy nano-booster unlocks wider therapeutic window for prostate cancer treatment. Acta Pharmaceutica Sinica B. 15(6). 3273–3290.
2.
3.
Lin, Ziqi, et al.. (2024). AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers. Cancer Cell International. 24(1). 283–283. 5 indexed citations
4.
Sun, Fei, Shipeng Ning, Xiaoyuan Fan, et al.. (2024). Engineered cytomembrane nanovesicles trigger in situ storm of engineered extracellular vesicles for cascade tumor penetration and immune microenvironment remodeling. Nano Today. 61. 102604–102604. 10 indexed citations
5.
Lin, Ziqi, Yuequan Wang, Wenwen Li, et al.. (2024). A natural compound-empowered podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy. Asian Journal of Pharmaceutical Sciences. 19(4). 100892–100892. 10 indexed citations
6.
Dai, Juji, Weicheng Liang, Lin Ye, et al.. (2023). PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. Cell Death and Disease. 14(6). 373–373. 5 indexed citations
7.
Wu, Qiushuang, et al.. (2023). Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application. Pharmacological Research. 188. 106654–106654. 22 indexed citations
8.
Yuan, Qin, Kaichun Wu, Zheng Zhang, et al.. (2022). NLRC3 deficiency promotes cutaneous wound healing due to the inhibition of p53 signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166518–166518. 12 indexed citations
9.
Gong, Huanfa, Zhimin Zhou, Tao Jiang, et al.. (2022). Mapping short tandem repeats for liver gene expression traits helps prioritize potential causal variants for complex traits in pigs. Journal of Animal Science and Biotechnology. 13(1). 8–8. 5 indexed citations
10.
Yu, Yan, Haiyan Zhu, Wenyi Zhang, et al.. (2022). RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 25(10). 105184–105184. 6 indexed citations
11.
Lin, Ziqi & Hang Fai Kwok. (2022). RUNDC3A/SNAP25/Akt signaling mediates tumor progression and chemoresistance in gastric neuroendocrine carcinoma. Cell Death and Disease. 13(10). 840–840. 3 indexed citations
12.
Zhang, Wenyi, Qian Zhang, Ziqi Lin, et al.. (2021). Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway. Oncogene. 40(45). 6369–6380. 17 indexed citations
13.
Chen, Chia‐Wei, et al.. (2021). A Novel Spo11 Homologue Functions as a Positive Regulator in Cyst Differentiation in Giardia lamblia. International Journal of Molecular Sciences. 22(21). 11902–11902. 2 indexed citations
14.
Dai, Xiaowei, Juji Dai, Zheng Zhang, et al.. (2020). AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death and Disease. 11(10). 822–822. 119 indexed citations
15.
Lin, Ziqi, et al.. (2019). Development of CRISPR/Cas9-mediated gene disruption systems in Giardia lamblia. PLoS ONE. 14(3). e0213594–e0213594. 19 indexed citations
16.
Lin, Ziqi, et al.. (2017). New Mitogenomes of Two Chinese Stag Beetles (Coleoptera, Lucanidae) and Their Implications for Systematics. Journal of Insect Science. 17(2). 21 indexed citations
17.
18.
Ge, Ning, Zhi Zeng, Ziqi Lin, Zhonghua Yang, & Qing Xia. (2014). [Endothelial protection of tanshinone in rats of severe acute pancreatitis].. PubMed. 45(2). 230–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian‐Zhi Ni Breakdown of academic impact, for papers by Fuqiang Huang Breakdown of academic impact, for papers by Kerstin Rönsch Breakdown of academic impact, for papers by Indi P. Joore Breakdown of academic impact, for papers by Manning Qian Breakdown of academic impact, for papers by H. Yue Breakdown of academic impact, for papers by Bowen Liu
Rankless by CCL
2026